Pharmacy

The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.

PBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.

Shocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch

Successful community initiatives are creating systems of care that bridge multiple programs to provide coordinated services to individuals with substance use disorders. Here are five.

Overprescribing by just one practitioner can lead to an untoward outcome that may readily affect the entire healthcare facility.

A Walgreens study sheds light on the benefits of patient-centered pharmacy-based programs.

The Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.

The Innovation and Value Initiative launched the Open-Source Value Project, creating tools that help payers, providers, and healthcare systems make informed and patient-centered decisions that produce better health outcomes.

A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.

While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a new study counters that belief.

A new study reveals an important spillover effect of parental Medicaid coverage.

One expert says the interoperability of medical devices, especially of IoT medical devices, creates soft spots in an organization’s security framework.

A sneak peek at the findings from our 2018 Technology Survey reveal where healthcare organizations are struggling most when it comes to interoperability and Big Data.

Fitbit devices will be used for an NIH research program to explore the influence of behavioral, biological, and environmental influences on health.

Two new studies address the financial implications of unexpected major healthcare expenses for common cardiovascular conditions and procedures.

Healthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.

A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.

Treating RA is a work in progress. Here’s what you need to know.

Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.

Here are six healthcare impact trends that will challenge marketers in the upcoming year.

A new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.

A commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.

Plans must be able to deploy these five tactics, whether using internal resources or collaborating with a vendor.

The National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.

Researchers share surprising findings about PCT-guided therapy in antibiotic management in patients with respiratory infections.